Clinical Trials Browser

Phase 2 × Has results × pomalidomide × Clear all

NCT04802161 2025-12-19

Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes

Phase 2 Active not recruiting

50 enrolled 12 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT04191616 2025-09-04

SELECT

Phase 2 Completed

54 enrolled 17 charts

Plasma cell

Multiple Myeloma, Recurrence

NCT05288062 2025-08-20

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Phase 2 Terminated

17 enrolled 9 charts

Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

NCT03713294 2025-06-24

Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma

Phase 2 Completed

37 enrolled 11 charts

Plasma cell

Multiple Myeloma

NCT04892446 2025-05-02

Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma

Phase 2 Terminated

36 enrolled 17 charts

Plasma cell

Multiple Myeloma

NCT04700176 2025-02-25

A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma

Phase 2 Terminated

1 enrolled 14 charts

Plasma cell

Multiple Myeloma

NCT03257631 2024-04-16

A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

Phase 2 Completed

53 enrolled 18 charts

CNS

Brain Neoplasms, Ependymoma, Glioma, Medulloblastoma, Central Nervous System Neoplasms

NCT02547662 2023-10-30

Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia

Phase 2 Completed

17 enrolled 13 charts

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma, Plasmacytoma

NCT04843579 2023-10-25

ClaSPd

Phase 2 Terminated

4 enrolled 9 charts

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03202628 2023-09-21

Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

8 enrolled 14 charts

Plasma cell

Multiple Myeloma

NCT01177735 2021-04-22

Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma

Phase 2 Completed

71 enrolled 7 charts

Plasma cell

Multiple Myeloma, Recurrence

NCT00463385 2019-11-20

A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia

Phase 2 Completed

88 enrolled 22 charts

MyeloidOther hematologic neoplasm

Leukemia, Megakaryoblastic, Acute, Primary Myelofibrosis

NCT00717522 2019-11-19

Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma

Phase 2 Terminated

7 enrolled 7 charts

Sarcoma

NCT01159574 2019-06-11

Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma

Phase 2 Completed

121 enrolled 9 charts

Plasma cell

Multiple Myeloma

NCT01794039 2018-08-21

Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide

Phase 2 Completed

9 enrolled 10 charts

Plasma cell

Multiple Myeloma

NCT00558896 2018-04-18

CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis

Phase 2 Completed

378 enrolled 13 charts

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02011113 2016-11-01

Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma

Phase 2 Completed

36 enrolled 18 charts

Plasma cell

Multiple Myeloma, Recurrence